Rosenquist Roger MD is categorized under Family Practice Doctors in Portland, OR and active since 1999.
Rosenquist Roger MD was established in 1999, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Family Practice Doctors business, which does work in the B2C market, and is classified as a Family Practice Doctors, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Roger Rosenquist at the company’s single location by writing to 10000 Se Main St # 342, Portland, Oregon OR 97216 or by phoning (503) 251-0020. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Rosenquist Roger MD |
| Contact Person: | Roger Rosenquist |
| Address: | 10000 Se Main St # 342, Portland, Oregon 97216 |
| Phone Number: | (503) 251-0020 |
| Website Address: | theurologyclinic.com |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Founded: | 1999 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Family Practice Doctors |
| SIC Code: | 8011 |
| NAICS Code: | 6211110 |
| Share This Business: |
Rosenquist Roger MD was started in 1999 to provide professional Family Practice Doctors under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Roger Rosenquist for inquiries that concern Rosenquist Roger MD by calling the company number (503) 251-0020, as your correspondence is most welcome. Additionally, the physical location of the single location of Rosenquist Roger MD can be found at the coordinates 45.514,-122.5596 as well as the street address 10000 Se Main St # 342 in Portland, Oregon 97216.
For its online presence, you may visit Rosenquist Roger MD’s website at theurologyclinic.com and engage with its social media outlets through on Twitter and on Facebook.